Mark Lebwohl, MD, discusses the new and emerging therapies for treatment of psoriasis, including:

Can you elaborate on the different classes of biologics currently indicated for treatment of psoriasis?

• What are some of the most promising therapies that will likely be part of the psoriasis treatment table in the near future?
• Do you foresee that they will be also approved for pediatric psoriasis patients, or only for the adult population?
• Where do you feel biologics fit in with the other approved treatments for psoriasis, or overall in the treatment regimen?
• Can you tell us what you feel is still needed in terms of developing new treatments for psoriasis?